Medicines for haemophilia remain in the high-cost protection after TLV's reconsideration

25 September 2020 - The costs of factor IX concentrate, which is used in the treatment of haemophilia B, are reduced ...

Read more →

HyQvia gets a higher price

8 May 2020 - HyQvia 100 mg/mL solution for injection contains human immunoglobulin, which is an antibody used to strengthen ...

Read more →

TLV is reviewing the subsidy of factor VIII drugs with side agreements

28 January 2020 - Factor VIII drugs are used to treat a form of hemorrhagic disease, hemophilia A, which involves ...

Read more →